{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:49:22Z","timestamp":1794030562291,"version":"4.8.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Ricerca Corrente"],"award-info":[{"award-number":["Ricerca Corrente"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007385","name":"Fondazione Cassa di Risparmio di Bologna","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007385","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Neurofilament light chain (NfL) and \u03b1-synuclein oligomeric seeds (\u03b1-syn-s) are promising biomarkers for patients with parkinsonism. We assessed their performance in discriminating Parkinson disease (PD) from atypical parkinsonisms (APDs) and evaluated the association between NfL levels and clinical measures of disease severity. We measured NfL in cerebrospinal fluid (CSF) and\/or plasma by immunoassays and \u03b1-syn-s in CSF by real-time quaking-induced conversion (RT-QuIC) in patients with PD (<jats:italic>n<\/jats:italic>\u2009=\u2009153), multiple system atrophy (MSA) (<jats:italic>n<\/jats:italic>\u2009=\u200980), progressive supranuclear palsy\/cortico-basal syndrome (PSP\/CBS) (<jats:italic>n<\/jats:italic>\u2009=\u200958), dementia with Lewy bodies (<jats:italic>n<\/jats:italic>\u2009=\u200964), isolated REM-sleep behaviour disorder (<jats:italic>n<\/jats:italic>\u2009=\u200919), and isolated autonomic failure (<jats:italic>n<\/jats:italic>\u2009=\u200930). Measures of disease severity included disease duration, UPDRS-III score, Hoehn and Yahr stage, orthostatic hypotension, MMSE score, and CSF amyloid-beta profile. Both CSF NfL (cNfL) and plasma NfL (pNfL) levels were markedly elevated in APDs, and allowed differentiation with PD (vs. APDs, cNfL AUC 0.96; pNfL AUC 0.95; vs. MSA cNfL AUC 0.99; pNfL AUC 0.97; vs. PSP\/CBS cNfL AUC 0.94; pNfL AUC 0.94). RT-QuIC detected \u03b1-syn-s in 91.4% of PD, but only 2.5% of APDs (all MSA). In PD\/PDD, motor scales significantly correlated with cNfL levels. Although pNfL and both cNfL and \u03b1-syn-s accurately distinguished PD from APDs, the combined assessment of CSF markers provided a higher diagnostic value (PD vs. APDs AUC 0.97; vs. MSA AUC 0.97; vs. PSP\/CBS AUC 0.99) than RT-QuIC alone (<jats:italic>p<\/jats:italic>\u2009=\u20090.047 vs. APDs;<jats:italic>p<\/jats:italic>\u2009=\u20090.002 vs MSA;<jats:italic>p<\/jats:italic>\u2009=\u20090.007 vs PSP\/CBS), or cNfL alone (<jats:italic>p<\/jats:italic>\u2009=\u20090.011 vs. APDs;<jats:italic>p<\/jats:italic>\u2009=\u20090.751 vs MSA;<jats:italic>p<\/jats:italic>\u2009=\u20090.0001 vs. PSP\/CBS). The results support the use of these assays in specialised clinics.<\/jats:p>","DOI":"10.1038\/s41531-021-00232-4","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T10:18:43Z","timestamp":1633947523000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":130,"title":["Neurofilament light chain and \u03b1-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0302-3027","authenticated-orcid":false,"given":"Corinne","family":"Quadalti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Calandra-Buonaura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Baiardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mastrangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Zenesini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Giannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccol\u00f2","family":"Candelise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Sambati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Polischi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Plazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Capellari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Cortelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9444-9524","authenticated-orcid":false,"given":"Piero","family":"Parchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,11]]},"reference":[{"key":"232_CR1","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","volume":"71","author":"S Gilman","year":"2008","unstructured":"Gilman, S. et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71, 670\u2013676 (2008).","journal-title":"Neurology"},{"key":"232_CR2","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/mds.27362","volume":"33","author":"RB Postuma","year":"2018","unstructured":"Postuma, R. B. et al. Validation of the MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 33, 1601\u20131608 (2018).","journal-title":"Mov. Disord."},{"key":"232_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/nan.12303","volume":"42","author":"RA Barker","year":"2016","unstructured":"Barker, R. A. & Williams-Gray, C. H. Review: The spectrum of clinical features seen with alpha synuclein pathology. Neuropathol. Appl. Neurobiol. 42, 6\u201319 (2016).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"232_CR4","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","volume":"90","author":"L Gaetani","year":"2019","unstructured":"Gaetani, L. et al. Neurofilament light chain as a biomarker in neurological disorders. J. Neurol. Neurosurg. Psychiatry 90, 870\u2013881 (2019).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"232_CR5","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/mds.28101","volume":"35","author":"H Zetterberg","year":"2020","unstructured":"Zetterberg, H. Is there a value of neurofilament light as a biomarker for neurodegeneration in Parkinson\u2019s disease? Mov. Disord. 35, 1111\u20131112 (2020).","journal-title":"Mov. Disord."},{"key":"232_CR6","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1212\/WNL.0000000000003680","volume":"88","author":"O Hansson","year":"2017","unstructured":"Hansson, O. et al. Blood-based NfL: a biomarker for differential diagnosis of parkinsonian disorder. Neurology 88, 930\u2013937 (2017).","journal-title":"Neurology"},{"key":"232_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-31517-z","volume":"8","author":"S Hall","year":"2018","unstructured":"Hall, S. et al. Cerebrospinal fluid concentrations of inflammatory markers in Parkinson\u2019s disease and atypical parkinsonian disorders. Sci. Rep. 8, 13276 (2018).","journal-title":"Sci. Rep."},{"key":"232_CR8","doi-asserted-by":"publisher","first-page":"e1104","DOI":"10.1212\/WNL.0000000000008088","volume":"93","author":"CH Lin","year":"2019","unstructured":"Lin, C. H. et al. Blood NfL: a biomarker for disease severity and progression in Parkinson disease. Neurology 93, e1104\u2013e1111 (2019).","journal-title":"Neurology"},{"key":"232_CR9","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1001\/archneurol.2012.1654","volume":"69","author":"S Hall","year":"2012","unstructured":"Hall, S. et al. Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and\/or parkinsonian disorders. Arch. Neurol. 69, 1445\u20131452 (2012).","journal-title":"Arch. Neurol."},{"key":"232_CR10","doi-asserted-by":"publisher","first-page":"e1479","DOI":"10.1212\/WNL.0000000000007179","volume":"92","author":"TM Marques","year":"2019","unstructured":"Marques, T. M. et al. Serum NFL discriminates Parkinson disease from atypical parkinsonisms. Neurology 92, e1479\u2013e1486 (2019).","journal-title":"Neurology"},{"key":"232_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s40478-020-00990-x","volume":"8","author":"N Candelise","year":"2020","unstructured":"Candelise, N., Baiardi, S., Franceschini, A., Rossi, M. & Parchi, P. Towards an improved early diagnosis of neurodegenerative diseases: the emerging role of in vitro conversion assays for protein amyloids. Acta Neuropathol. Commun. 8, 117 (2020).","journal-title":"Acta Neuropathol. Commun."},{"key":"232_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-020-02160-8","volume":"140","author":"M Rossi","year":"2020","unstructured":"Rossi, M. et al. Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies. Acta Neuropathol. 140, 49\u201362 (2020).","journal-title":"Acta Neuropathol."},{"key":"232_CR13","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/acn3.338","volume":"3","author":"G Fairfoul","year":"2016","unstructured":"Fairfoul, G. et al. Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies. Ann. Clin. Transl. Neurol. 3, 812\u2013818 (2016).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"232_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40478-018-0508-2","volume":"6","author":"BR Groveman","year":"2018","unstructured":"Groveman, B. R. et al. Rapid and ultra-sensitive quantitation of disease-associated \u03b1-synuclein seeds in brain and cerebrospinal fluid by \u03b1Syn RT-QuIC. Acta Neuropathol. Commun. 6, 7 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"232_CR15","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/ana.25447","volume":"85","author":"A van Rumund","year":"2019","unstructured":"van Rumund, A. et al. \u03b1-Synuclein real-time quaking-induced conversion in the cerebrospinal fluid of uncertain cases of parkinsonism. Ann. Neurol. 85, 777\u2013781 (2019).","journal-title":"Ann. Neurol."},{"key":"232_CR16","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/ana.25824","volume":"88","author":"W Singer","year":"2020","unstructured":"Singer, W. et al. Alpha-synuclein oligomers and neurofilament light chain in spinal fluid differentiate multiple system atrophy from lewy body synucleinopathies. Ann. Neurol. 88, 503\u2013512 (2020).","journal-title":"Ann. Neurol."},{"key":"232_CR17","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fneur.2015.00091","volume":"6","author":"MK Herbert","year":"2015","unstructured":"Herbert, M. K. et al. CSF neurofilament light chain but not FLT3 ligand discriminates Parkinsonian disorders. Front. Neurol. 6, 91 (2015).","journal-title":"Front. Neurol."},{"key":"232_CR18","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jamaneurol.2015.1449","volume":"72","author":"DC B\u00e4ckstr\u00f6m","year":"2015","unstructured":"B\u00e4ckstr\u00f6m, D. C. et al. Cerebrospinal fluid patterns and the risk of future dementia in early, incident Parkinson disease. JAMA Neurol. 72, 1175\u20131182 (2015).","journal-title":"JAMA Neurol."},{"key":"232_CR19","doi-asserted-by":"publisher","first-page":"e827","DOI":"10.1212\/WNL.0000000000010084","volume":"95","author":"D B\u00e4ckstr\u00f6m","year":"2020","unstructured":"B\u00e4ckstr\u00f6m, D. et al. NfL as a biomarker for neurodegeneration and survival in Parkinson disease. Neurology 95, e827\u2013e838 (2020).","journal-title":"Neurology"},{"key":"232_CR20","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1002\/mds.28206","volume":"35","author":"B Mollenhauer","year":"2020","unstructured":"Mollenhauer, B. et al. Validation of serum neurofilament light chain as a biomarker of Parkinson\u2019s disease progression. Mov. Disord. 35, 1999\u20132008 (2020).","journal-title":"Mov. Disord."},{"key":"232_CR21","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1002\/mds.28056","volume":"35","author":"S Lerche","year":"2020","unstructured":"Lerche, S. et al. CSF NFL in a longitudinally assessed PD cohort: age effects and cognitive trajectories. Mov. Disord. 35, 1138\u20131144 (2020).","journal-title":"Mov. Disord."},{"key":"232_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jns.2008.12.037","volume":"279","author":"A Petzold","year":"2009","unstructured":"Petzold, A. et al. Longitudinal one-year study of levels and stoichiometry of neurofilament heavy and light chain concentrations in CSF in patients with multiple system atrophy. J. Neurol. Sci. 279, 76\u201379 (2009).","journal-title":"J. Neurol. Sci."},{"key":"232_CR23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13195-019-0485-0","volume":"11","author":"O Hansson","year":"2019","unstructured":"Hansson, O., Lehmann, S., Otto, M., Zetterberg, H. & Lewczuk, P. Advantages and disadvantages of the use of the CSF Amyloid \u03b2 (A\u03b2) 42\/40 ratio in the diagnosis of Alzheimer\u2019s Disease. Alzheimers Res. Ther. 11, 34 (2019).","journal-title":"Alzheimers Res. Ther."},{"key":"232_CR24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13195-020-00703-5","volume":"12","author":"JG Goldman","year":"2020","unstructured":"Goldman, J. G. et al. Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials. Alzheimers Res. Ther. 12, 137 (2020).","journal-title":"Alzheimers Res. Ther."},{"key":"232_CR25","first-page":"1","volume":"78","author":"Z Wang","year":"2020","unstructured":"Wang, Z. et al. Skin \u03b1-synuclein aggregation seeding activity as a novel biomarker for Parkinson disease. JAMA Neurol. 78, 1\u201311 (2020).","journal-title":"JAMA Neurol."},{"key":"232_CR26","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1212\/WNL.0000000000000316","volume":"82","author":"V Donadio","year":"2014","unstructured":"Donadio, V. et al. Skin nerve \u03b1-synuclein deposits: a biomarker for idiopathic Parkinson disease. Neurology 82, 1362\u20131369 (2014).","journal-title":"Neurology"},{"key":"232_CR27","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1007\/s10072-020-04305-9","volume":"4","author":"G Calandra-Buonaura","year":"2020","unstructured":"Calandra-Buonaura, G. et al. The Bologna motor and non-motor prospective study on parkinsonism at onset (BoProPark): study design and population. Neurol. Sci. 4, 2531\u20132537 (2020).","journal-title":"Neurol. Sci."},{"key":"232_CR28","doi-asserted-by":"publisher","first-page":"e1245","DOI":"10.1212\/WNL.0000000000006243","volume":"91","author":"G Giannini","year":"2018","unstructured":"Giannini, G. et al. The natural history of idiopathic autonomic failure: the IAF-BO cohort study. Neurology 91, e1245\u2013e1254 (2018).","journal-title":"Neurology"},{"key":"232_CR29","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1378\/chest.14-0970","volume":"146","author":"MJ Sateia","year":"2014","unstructured":"Sateia, M. J. International classification of sleep disorders-third edition: highlights and modifications. Chest 146, 1387\u20131394 (2014).","journal-title":"Chest"},{"key":"232_CR30","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s004150200062","volume":"249","author":"MP Chandler","year":"2002","unstructured":"Chandler, M. P. & Mathias, C. J. Haemodynamic responses during head-up tilt and tilt reversal in two groups with chronic autonomic failure: pure autonomic failure and multiple system atrophy. J. Neurol. 249, 542\u2013548 (2002).","journal-title":"J. Neurol."},{"key":"232_CR31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/B978-0-444-53491-0.00020-1","volume":"117","author":"EM Garland","year":"2013","unstructured":"Garland, E. M., Hooper, W. B. & Robertson, D. Pure autonomic failure. Handb. Clin. Neurol. 117, 243\u2013257 (2013).","journal-title":"Handb. Clin. Neurol."},{"key":"232_CR32","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 30, 1591\u20131601 (2015).","journal-title":"Mov. Disord."},{"key":"232_CR33","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","volume":"32","author":"GU H\u00f6glinger","year":"2017","unstructured":"H\u00f6glinger, G. U. et al. Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov. Disord. 32, 853\u2013864 (2017).","journal-title":"Mov. Disord."},{"key":"232_CR34","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","volume":"80","author":"MJ Armstrong","year":"2013","unstructured":"Armstrong, M. J. et al. Criteria for the diagnosis of corticobasal degeneration. Neurology 80, 496\u2013503 (2013).","journal-title":"Neurology"},{"key":"232_CR35","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1111\/j.1742-1241.2008.01869.x","volume":"62","author":"W Poewe","year":"2008","unstructured":"Poewe, W. et al. Diagnosis and management of Parkinson\u2019s disease dementia. Int. J. Clin. Pract. 62, 1581\u20131587 (2008).","journal-title":"Int. J. Clin. Pract."},{"key":"232_CR36","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith, I. G. et al. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 89, 88\u2013100 (2017).","journal-title":"Neurology"},{"key":"232_CR37","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","volume":"94","author":"IG McKeith","year":"2020","unstructured":"McKeith, I. G. et al. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology 94, 743\u2013755 (2020).","journal-title":"Neurology"},{"key":"232_CR38","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/nrneurol.2017.157","volume":"14","author":"B H\u00f6gl","year":"2018","unstructured":"H\u00f6gl, B., Stefani, A. & Videnovic, A. Idiopathic REM sleep behaviour disorder and neurodegeneration - an update. Nat. Rev. Neurol. 14, 40\u201355 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"232_CR39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/acn3.697","volume":"6","author":"S Baiardi","year":"2018","unstructured":"Baiardi, S. et al. Antemortem CSF A\u03b242\/A\u03b240 ratio predicts Alzheimer\u2019s disease pathology better than A\u03b242 in rapidly progressive dementias. Ann. Clin. Transl. Neurol. 6, 263\u2013273 (2018).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"232_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13195-017-0331-1","volume":"10","author":"S Abu-Rumeileh","year":"2018","unstructured":"Abu-Rumeileh, S. et al. The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias. Alzheimers Res. Ther. 10, 3 (2018).","journal-title":"Alzheimers Res. Ther."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-021-00232-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-021-00232-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-021-00232-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T23:09:55Z","timestamp":1699657795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-021-00232-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,11]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["232"],"URL":"https:\/\/doi.org\/10.1038\/s41531-021-00232-4","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,11]]},"assertion":[{"value":"16 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Giuseppe Plazzi participated in advisory board for UCB Pharma, Jazz pharmaceuticals, Bioprojet, Takeda and Idorsia. All other authors declare no conflict of interest or disclosures.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"93"}}